SMN1 and sarcopenia: Not only does myosteatosis have the potential to reduce SMRA levels resulting in an increased incidence of sarcopenia as defined by SMRA, but it may also have the potential to obscure the relevance of SMA and SMI as predictors of sarcopenia in overweight populations as increasing tissue adiposity may result in maintained or even increased muscle surface area [23].